Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Public ClinicalTrials.gov record NCT01731119. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Study identification
- NCT ID
- NCT01731119
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- University of North Carolina, Chapel Hill
- Other
- Enrollment
- 9 participants
Conditions and interventions
Conditions
- Asperger Syndrome
- Autistic Disorder
- Bipolar I Disorder
- Bipolar II Disorder
- Child Development Disorders, Pervasive
- Mood Disorder NOS
- Psychosis NOS
- Schizoaffective Disorder
- Schizophrenia
- Schizophreniform Disorder
- Severe Major Depression With Psychotic Features
- Severe Mood Disorder With Psychotic Features
- Single Episode Major Depression Without Psychotic Symptoms
Interventions
- Latuda© Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 19 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2012
- Primary completion
- Jul 31, 2014
- Completion
- Jul 31, 2014
- Last update posted
- Jun 13, 2017
2012 – 2014
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of North Carolina | Chapel Hill | North Carolina | 27517 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01731119, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 13, 2017 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01731119 live on ClinicalTrials.gov.